- Report
- April 2023
- 114 Pages
Global
From €4258EUR$4,750USD£3,689GBP
- Report
- August 2023
- 116 Pages
Global
From €4034EUR$4,500USD£3,495GBP
- Report
- January 2024
- 171 Pages
Global
From €2241EUR$2,500USD£1,942GBP
- Report
- April 2023
- 147 Pages
Global
From €4436EUR$4,949USD£3,844GBP
- Report
- April 2024
- 120 Pages
Global
From €2857EUR$3,188USD£2,476GBP
€3810EUR$4,250USD£3,301GBP
- Report
- February 2026
- 150 Pages
Germany
From €4348EUR$4,850USD£3,767GBP
- Report
- February 2026
- 150 Pages
India
From €4348EUR$4,850USD£3,767GBP
- Report
- February 2026
- 150 Pages
Canada
From €4348EUR$4,850USD£3,767GBP
- Report
- February 2026
- 150 Pages
China
From €4348EUR$4,850USD£3,767GBP
- Report
- December 2024
- 150 Pages
Global
From €4348EUR$4,850USD£3,767GBP
- Report
- January 2024
- 150 Pages
Global
From €4348EUR$4,850USD£3,767GBP
From €4348EUR$4,850USD£3,767GBP
- Report
- October 2025
- 83 Pages
Saudi Arabia
From €4348EUR$4,850USD£3,767GBP
- Report
- April 2023
- 192 Pages
North America
From €7162EUR$7,990USD£6,206GBP
- Report
- April 2023
- 306 Pages
Europe
From €7162EUR$7,990USD£6,206GBP
- Report
- April 2023
- 306 Pages
Asia Pacific
From €7162EUR$7,990USD£6,206GBP
- Report
- March 2023
- 71 Pages
Canada
From €2685EUR$2,995USD£2,326GBP
- Report
- March 2023
- 71 Pages
Australia
From €2685EUR$2,995USD£2,326GBP
- Report
- March 2023
- 71 Pages
India
From €2685EUR$2,995USD£2,326GBP
- Report
- March 2023
- 71 Pages
Germany
From €2685EUR$2,995USD£2,326GBP

The Kidney Transplant market is a subset of the biotechnology industry that focuses on the development of treatments and technologies related to kidney transplantation. This includes the development of new drugs, medical devices, and surgical techniques to improve the safety and efficacy of kidney transplantation. Additionally, the market includes research into the development of new immunosuppressive drugs to reduce the risk of organ rejection.
The Kidney Transplant market is highly competitive, with many companies vying for a share of the market. Companies in the market include Astellas Pharma, Novartis, Roche, Merck, and Pfizer. Additionally, there are a number of smaller companies that specialize in the development of new treatments and technologies related to kidney transplantation. Show Less Read more